BridgeBio Pharma (BBIO) Change in Inventory (2025 - 2026)

BridgeBio Pharma's (BBIO) quarterly Change in Inventory came in at $7.1 million in Q1 2026, up 120.89% year-on-year from $3.2 million in Q1 2025, and up 261.51% quarter-over-quarter from $2.0 million in Q4 2025.

BridgeBio Pharma (BBIO) Change in Inventory (2025 - 2026) Analysis & Trends

BridgeBio Pharma has disclosed Change in Inventory across 2 years of filings, most recently posting $7.1 million for Q1 2026.

  • Change in Inventory for Q1 2026 came in at $7.1 million, up 120.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $29.2 million (up 813.47% YoY), and the FY2025 annual result was $25.3 million, changed N/A from the prior year.
  • Change in Inventory came in at $7.1 million for Q1 2026 at BridgeBio Pharma, up from $2.0 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $13.4 million in Q2 2025 to a low of $2.0 million in Q4 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 51,468.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 97.70 Mn
9 Abivax 91.96 Bn 91.96 Bn - -
10 BridgeBio Pharma 12.90 Bn 11.97 Bn 184.58 Mn 7.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.05 Mn
Mar 31, 2026 7.05 Mn
Dec 31, 2025 1.95 Mn
Dec 31, 2025 1.95 Mn
Sep 30, 2025 6.77 Mn
Sep 30, 2025 6.77 Mn
Jun 30, 2025 13.39 Mn
Jun 30, 2025 13.39 Mn
Mar 31, 2025 3.19 Mn
Mar 31, 2025 3.19 Mn